Addus HomeCare (NASDAQ:ADUS) Cut to Buy at Wall Street Zen

Wall Street Zen lowered shares of Addus HomeCare (NASDAQ:ADUS) from a strong-buy rating to a buy rating in a research note issued to investors on Sunday morning.

Other equities research analysts have also issued reports about the stock. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Addus HomeCare in a report on Wednesday, January 21st. Royal Bank Of Canada upped their price objective on shares of Addus HomeCare from $134.00 to $139.00 and gave the company an “outperform” rating in a research report on Friday, November 7th. Truist Financial set a $135.00 target price on Addus HomeCare and gave the stock a “buy” rating in a research report on Wednesday, January 7th. Barclays increased their price target on Addus HomeCare from $111.00 to $117.00 and gave the company an “underweight” rating in a report on Tuesday, November 4th. Finally, BMO Capital Markets assumed coverage on Addus HomeCare in a report on Thursday, November 13th. They set a “market perform” rating and a $120.00 price objective on the stock. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $135.44.

Addus HomeCare Stock Performance

Addus HomeCare stock opened at $113.26 on Friday. The firm has a market capitalization of $2.09 billion, a PE ratio of 24.25, a price-to-earnings-growth ratio of 1.37 and a beta of 0.91. Addus HomeCare has a one year low of $88.96 and a one year high of $124.43. The stock’s 50 day moving average price is $109.80 and its 200 day moving average price is $113.05. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.66 and a current ratio of 1.66.

Institutional Investors Weigh In On Addus HomeCare

A number of institutional investors have recently modified their holdings of ADUS. Global Retirement Partners LLC lifted its holdings in Addus HomeCare by 395.7% in the fourth quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock worth $25,000 after acquiring an additional 186 shares during the last quarter. Larson Financial Group LLC raised its position in shares of Addus HomeCare by 133.3% during the 3rd quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock worth $28,000 after purchasing an additional 136 shares during the period. Acumen Wealth Advisors LLC bought a new stake in shares of Addus HomeCare in the 4th quarter worth approximately $29,000. Private Trust Co. NA lifted its holdings in shares of Addus HomeCare by 65.5% in the 4th quarter. Private Trust Co. NA now owns 283 shares of the company’s stock worth $30,000 after purchasing an additional 112 shares during the last quarter. Finally, Arax Advisory Partners boosted its position in Addus HomeCare by 95.8% during the 4th quarter. Arax Advisory Partners now owns 280 shares of the company’s stock valued at $30,000 after purchasing an additional 137 shares during the period. Institutional investors own 95.35% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.